Latest News

The Motley Fool recently surveyed 2,000 individual investors to gauge their optimism about the stock market and their concerns.

Centrus Energy is America's premier uranium enricher, but there are some nuances to this story.

Credit cards aren't always the right move. Here are three situations where using your debit card (or cash) is the smarter financial choice.

AbbVie's dividend yield is far above the market's, and the dividend has been growing for years.

Casual restaurant chain Portillo’s (NASDAQ:PTLO) met Wall Street’s revenue expectations in Q4 CY2025, but sales were flat year on year at $185.7 million. Its GAAP profit of $0.08 per share was 74.3% above analysts’ consensus estimates.

Modular flooring manufacturer Interface (NASDAQ:TILE) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 4.3% year on year to $349.4 million. The company expects next quarter’s revenue to be around $320 million, slightly above analysts’ estimates. Its non-GAAP profit of $0.49 per share was 21.5% above analysts’ consensus estimates.

Buffett kept it simple: buy good stocks, wait, get dividends. Here's how to do the same thing.

Industrial equipment and engineered products manufacturer Albany (NYSE:AIN) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 12% year on year to $321.2 million. Its non-GAAP profit of $0.65 per share was 7.4% below analysts’ consensus estimates.

Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.7% year on year to $3.44 billion. Its GAAP profit of $0.85 per share was 16.4% below analysts’ consensus estimates.

Over the past couple of weeks, money looks to be moving out of stocks and into bonds. That could be a dangerous sign for stock investors.

Aerospace and defense company Leonardo DRS (NASDAQ:DRS) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 8.1% year on year to $1.06 billion. The company’s full-year revenue guidance of $3.9 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $0.42 per share was 13.2% above analysts’ consensus estimates.

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 18.1% year on year to $197.9 million. The company expects the full year’s revenue to be around $825 million, close to analysts’ estimates. Its non-GAAP profit of $0.49 per share was 10.4% above analysts’ consensus estimates.

Blue Hat announced the pricing of its public offering of 32 million units last week, at a price of $0.2 per unit.

The UK government has announced that streaming services such as Netflix Inc. (NASDAQ: NFLX), Amazon.com Inc. (NASDAQ: AMZN) Prime Video, and Disney+ from Walt Disney Co. (NYSE: DIS) will now be regulated under the same rules as traditional broadcasters like the BBC.

CoreWeave is a unique AI play, but risks abound.

WBD also noted that the merger agreement with Netflix remains in effect, adding that the WBD board continues to recommend it over the Paramount offer.

The two companies will work together to integrate advanced AI capabilities into Intuit’s suite of financial and business tools, creating solutions that simplify workflows.